|
Primary therapy
| |
|
Radical prostatectomy n (%)
|
38/43 (88.4%)
|
|
Radiotherapy n (%)
|
5/43 (11.6%)
|
|
Age at primary therapy (years)
| |
|
Mean/SD/median/range
|
60.3/6.1/60.0/74 - 46
|
|
Pathologic Gleason score at primary therapy n (%)
| |
|
6
|
4/43 (9%)
|
|
7
|
21/43 (49%)
|
|
8
|
7/43 (16%)
|
|
9
|
9/43 (21%)
|
|
x
|
2/43 (5%)
|
|
pT-stage at primary therapy n (%)
| |
|
T2
|
16/43 (37%)
|
|
T3
|
26/43 (61%)
|
|
T4
|
1/43 (2%)
|
|
pN-stage at primary therapy n (%)
| |
|
pN0
|
27/43 (63%)
|
|
pN1
|
12/43 (28%)
|
|
pNx
|
4/43 (9%)
|
|
Positive surgical margin at primary therapy n (%)
| |
|
R0
|
17/43 (39%)
|
|
R1
|
14/43 (33%)
|
|
Rx
|
12/43 (28%)
|
|
Initial PSA at primary therapy (ng/ml)
| |
|
Mean/SD/median/range
|
16.4/14.83/10.9/4.2 – 24.96
|
